{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.50 vs. cons $1.47",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.39B vs. cons $3.38B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Capital Markets recurring revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~4.5% vs. cons ~3.6% (Q1 run-rate)",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~30.5% vs. cons 30-31% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 adjusted EPS growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~9% vs. cons 8-10% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 free cash flow",
      "prediction": "BETTER",
      "answer": "guide ~$2.15B vs. cons ~$2.10B midpoint (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 EBITDA margin expansion (pro forma bps)",
      "prediction": "UNKNOWN",
      "answer": "guide ~90bps vs. cons ~95-110bps FY implied run-rate (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.4,
  "day5_path": "FADE",
  "day5_rationale": "Stock already rallied ~12% into the print, front-running an expected in-line-to-modest beat versus FIS's own guidance (revenue/EPS near guide midpoints); with FY26 targets reiterated rather than raised and Capital Markets reacceleration still unproven amid lingering lending softness, initial pop likely gets partially given back as sell-side models true up estimates only modestly and profit-taking sets in after the pre-earnings run-up.",
  "day5_confidence": "LOW"
}